Indication
Vascular Anomalies
2 clinical trials
2 products
1 drug
Clinical trial
A Modular Open Label, Signal Seeking, Phase II Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations (TARGET-VM)Status: Not yet recruiting, Estimated PCD: 2026-06-01
Drug
AlpelisibProduct
MirdametinibClinical trial
Percutaneous Administration of Sirolimus in the Treatment of Superficial Complicated Vascular Anomalies: a Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2025-11-01
Product
Sirolimus